S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
Apple says it will fix software problems blamed for making iPhone 15 models too hot to handle
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
A fight over precious groundwater in a rural California town is rooted in carrots
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
Apple says it will fix software problems blamed for making iPhone 15 models too hot to handle
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
A fight over precious groundwater in a rural California town is rooted in carrots
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
Apple says it will fix software problems blamed for making iPhone 15 models too hot to handle
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
A fight over precious groundwater in a rural California town is rooted in carrots
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
Apple says it will fix software problems blamed for making iPhone 15 models too hot to handle
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
A fight over precious groundwater in a rural California town is rooted in carrots
NASDAQ:GDRX

GoodRx (GDRX) Stock Forecast, Price & News

$5.63
+0.10 (+1.81%)
(As of 09/29/2023 ET)
Compare
Today's Range
$5.52
$5.66
50-Day Range
$5.40
$9.24
52-Week Range
$3.82
$9.37
Volume
855,088 shs
Average Volume
884,650 shs
Market Capitalization
$2.24 billion
P/E Ratio
187.73
Dividend Yield
N/A
Price Target
$8.44

GoodRx MarketRank™ Forecast

Analyst Rating
Hold
2.36 Rating Score
Upside/​Downside
49.9% Upside
$8.44 Price Target
Short Interest
Bearish
10.46% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.79mentions of GoodRx in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
25.00%
From $0.08 to $0.10 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.39 out of 5 stars

Medical Sector

305th out of 971 stocks

Data Processing & Preparation Industry

26th out of 58 stocks


GDRX stock logo

About GoodRx (NASDAQ:GDRX) Stock

GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services. It serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. GoodRx Holdings, Inc. was incorporated in 2015 and is headquartered in Santa Monica, California.

GDRX Price History

GDRX Stock News Headlines

Better Than Oil Stocks
The best way to profit from energy is NOT a stock...Rather, it's this little-known alternative investment. 
ICLR vs. GDRX: Which Stock Is the Better Value Option?
What 15 Analyst Ratings Have To Say About GoodRx Holdings
Elon Did It Again: This Could be Bigger than Tesla
Love him or hate him, it’s hard to deny Elon Musk is a genius. After revolutionizing online payment processing (PayPal), space exploration (SpaceX), and the auto industry (Tesla)... He’s getting ready to do it again with his new AI venture.
GoodRx Holdings Inc.
13 Analysts Have This to Say About GoodRx Holdings
Credit Suisse Reaffirms Their Hold Rating on GoodRx Holdings (GDRX)
GoodRx (GDRX) Q2 2023 Earnings Call Transcript
GoodRx Holdings Q2 Adj. Profit Rises
See More Headlines
Receive GDRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GoodRx and its competitors with MarketBeat's FREE daily newsletter.

GDRX Company Calendar

Last Earnings
8/09/2023
Today
10/01/2023
Next Earnings (Estimated)
11/14/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Data processing & preparation
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:GDRX
Fax
N/A
Employees
952
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$8.44
High Stock Price Forecast
$12.00
Low Stock Price Forecast
$6.50
Forecasted Upside/Downside
+49.9%
Consensus Rating
Hold
Rating Score (0-4)
2.36
Research Coverage
14 Analysts

Profitability

Net Income
$-32,830,000.00
Pretax Margin
-1.52%

Debt

Sales & Book Value

Annual Sales
$745.09 million
Cash Flow
$0.23 per share
Book Value
$2.05 per share

Miscellaneous

Free Float
392,395,000
Market Cap
$2.24 billion
Optionable
Not Optionable
Beta
1.13
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Mr. Trevor BezdekMr. Trevor Bezdek (Age 45)
    Co-founder & Chairman
    Comp: $537k
  • Mr. Douglas Joseph HirschMr. Douglas Joseph Hirsch (Age 52)
    Co-founder, Chief Mission Officer & Director
    Comp: $507.29k
  • Mr. Karsten Ian VoermannMr. Karsten Ian Voermann (Age 53)
    CFO & Principal Financial Officer
    Comp: $693.69k
  • Mr. Raj Beri (Age 48)
    Chief Operating Officer
    Comp: $1.11M
  • Mr. Romin Nabiey (Age 36)
    Chief Accounting Officer & Principal Accounting Officer
    Comp: $516k
  • Mr. Scott W. Wagner (Age 52)
    Interim Chief Exec. Officer
  • Ms. Whitney Notaro
    VP of Investor Relations
  • Mr. Andrew SlutskyMr. Andrew Slutsky (Age 36)
    Chief Marketing Officer
  • Ms. Vina M. Leite (Age 53)
    Chief People Officer
  • Mr. Bansi NagjiMr. Bansi Nagji (Age 58)
    Pres of Healthcare













GDRX Stock - Frequently Asked Questions

Should I buy or sell GoodRx stock right now?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GoodRx in the last year. There are currently 9 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" GDRX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GDRX, but not buy additional shares or sell existing shares.
View GDRX analyst ratings
or view top-rated stocks.

What is GoodRx's stock price forecast for 2023?

14 brokerages have issued 1 year price targets for GoodRx's shares. Their GDRX share price forecasts range from $6.50 to $12.00. On average, they anticipate the company's stock price to reach $8.44 in the next year. This suggests a possible upside of 49.9% from the stock's current price.
View analysts price targets for GDRX
or view top-rated stocks among Wall Street analysts.

How have GDRX shares performed in 2023?

GoodRx's stock was trading at $4.66 at the beginning of 2023. Since then, GDRX shares have increased by 20.8% and is now trading at $5.63.
View the best growth stocks for 2023 here
.

When is GoodRx's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 14th 2023.
View our GDRX earnings forecast
.

How were GoodRx's earnings last quarter?

GoodRx Holdings, Inc. (NASDAQ:GDRX) issued its earnings results on Wednesday, August, 9th. The company reported $0.02 EPS for the quarter, beating analysts' consensus estimates of $0.01 by $0.01. The company earned $189.68 million during the quarter, compared to the consensus estimate of $186.90 million. GoodRx had a trailing twelve-month return on equity of 2.44% and a net margin of 1.58%.

What ETFs hold GoodRx's stock?
What guidance has GoodRx issued on next quarter's earnings?

GoodRx updated its third quarter 2023 earnings guidance on Thursday, August, 10th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $186.00 million-$190.00 million, compared to the consensus revenue estimate of $192.58 million.

What other stocks do shareholders of GoodRx own?

Based on aggregate information from My MarketBeat watchlists, some companies that other GoodRx investors own include Gilead Sciences (GILD), NVIDIA (NVDA), AbbVie (ABBV), Bristol-Myers Squibb (BMY), DraftKings (DKNG), GW Pharmaceuticals (GWPH), Rocket Companies (RKT), AT&T (T), Advanced Micro Devices (AMD) and Alteryx (AYX).

When did GoodRx IPO?

(GDRX) raised $900 million in an IPO on Wednesday, September 23rd 2020. The company issued 34,600,000 shares at a price of $24.00-$28.00 per share. Morgan Stanley, Goldman Sachs, J.P. Morgan and Barclays acted as the underwriters for the IPO and BofA Securities, Citigroup, Credit Suisse, RBC Capital Markets, UBS Investment Bank, Cowen, Deutsche Bank Securities, Evercore ISI, Citizens Capital Markets, KKR, LionTree, Raymond James, SVB Leerink, Academy Securities, Loop Capital Markets, R. Seelaus and Ramirez were co-managers.

What is GoodRx's stock symbol?

GoodRx trades on the NASDAQ under the ticker symbol "GDRX."

How do I buy shares of GoodRx?

Shares of GDRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is GoodRx's stock price today?

One share of GDRX stock can currently be purchased for approximately $5.63.

How much money does GoodRx make?

GoodRx (NASDAQ:GDRX) has a market capitalization of $2.24 billion and generates $745.09 million in revenue each year. The company earns $-32,830,000.00 in net income (profit) each year or $0.03 on an earnings per share basis.

How many employees does GoodRx have?

The company employs 952 workers across the globe.

How can I contact GoodRx?

GoodRx's mailing address is 233 WILSHIRE BLVD. SUITE 990, SANTA MONICA CA, 90401. The official website for the company is www.goodrx.com. The company can be reached via phone at 855-268-2822 or via email at alex@blueshirtgroup.com.

This page (NASDAQ:GDRX) was last updated on 10/1/2023 by MarketBeat.com Staff

My Account -